FDA clears 10 million J&J vaccine doses from contaminated Baltimore plant
Posted on AllSides June 11th, 2021
From The Center
The Food and Drug Administration said Friday that it's allowing for the release of two batches of the Johnson & Johnson COVID-19 vaccine made at the Emergent BioSolutions facility in Baltimore, where 100 million doses had been set aside for review after an accidental contamination.
Why it matters: The two authorized batches amount to approximately 10 million doses of J&J's single-shot vaccine, according to AP. The doses could end up being used in the U.S. or exported to other countries.
The state of play: The FDA said it conducted a "thorough review of...
